Elevated levels of CA 125 have been shown to be present in the serum o
f patients with ovarian carcinoma, non-gynaecological cancers and some
benign diseases. However, the value of CA 125 in malignant peritoneal
mesothelioma has not been studied in detail. Therefore, 7 patients wi
th diffuse malignant mesothelioma were included in this study. Median
age was 52.4 (range 16-73), and 6 of them were women. The mean serum C
A 125 level was 308 kU/1 (range 8-1,300 kU/1). Serum CA 125 concentrat
ions were found to be elevated in all 6 female patients. In 3 patients
, serum CA 125 levels were followed prospectively and showed a very cl
ose correlation with the response to chemotherapy. In 2 responder pati
ents, initially elevated CA 125 levels returned to normal during remis
sion after chemotherapy. In 1 non-responder patient, the serum CA 125
level continued to rise. In conclusion, the serum CA 125 level might b
e helpful in the diagnosis and follow-up of malignant peritoneal mesot
helioma.